瘦狐狸 wrote:
AAPL?這麼好怎麼...(恕刪)
市值
593,4億
營收
1487億
就算AAPL跌到今日633，PSR還有4，算不上便宜!!
AAPL.AMZN.GOOG.MSFT這些大巨人焦點也都在多屏一雲上，請較狐大AAPL優勢有喪失嗎?
當時火紅如HGSI
Jan 16, 1998 才9.09
Mar 1, 2000 飆到116.38 記得是當時市值第二大生技股
研發新藥有夢最美，未來大大的賺錢
2012年7月16日，HGSI下場是同意葛蘭素史克公司斥資36億美元併購
現在股價14.2，市值只剩2.85B
GlaxoSmithKline buys Human Genome Sciences for $3.6B
British drugmaker GlaxoSmithKline has agreed to pay $3.6 billion for Rockville-based Human Genome Sciences after a months-long acquisition dispute over the company’s true value.
Glaxo has extended multiple buyout offers since April to both the HGS board of directors and its shareholders that valued the company at $2.6 billion, or $13 per share, but the company repeatedly rejected them as too low.
This latest agreement will fetch $14.25 per share in cash for HGS, a transaction value worth about $3.6 billion on an equity basis, or approximately $3 billion net of cash and debt, the companies said.
The deal brings an end to what had become an increasingly heated battle for control of the company.
Glaxo had attempted to bypass the board and purchase stock directly from investors. HGS then thwarted that effort with a poison pill, but gained a lawsuit from some disgruntled shareholders in response.
The two firms are development and marketing partners on several drugs, including Benlysta, which was approved by the Food and Drug Administration last year to treat systemic lupus.
hypersonic7700 wrote:
上述所提都是大藥廠，...(恕刪)
Amgen Inc. (AMGN) -NasdaqGS
1998.1.12才12.25元
到2000.7.17 飆到78元 成為生技股龍頭老大
經過12年今日股價為89.2元，算是不錯，市值還有68.75B,但也只有AAPL的九分之一
跟他差一個字的AMZN，市值也比他多570億
Affymetrix (NASDAQ: AFFX) 再講另一個生技股，非開發新藥，而是開發DNA microarrays也為當時焦點之一
1998.8.24才9元
到2000.2.28居然飆到160元，不到2年這報酬率驚人吧
經過12年今日股價為3.58元，市值只有252.79M
所以炒作的時候，還在看財报嗎，簡直遜斃了
通通漲拉,尤其故事越夢幻的公司漲幅越多
內文搜尋
從 APP 打開
X